This site will look much better in a browser that supports web standards, but it is accessible to any browser or Internet device.

Skip Navigation skip menu and banner
University of Wyoming

PhRMA Guidelines


Guidelines for Participation by PhRMA in
Wyoming Drug Utilization Review Board Meetings 

  1. PhRMA representatives may provide relevant material for Board review in advance of scheduled meetings. The Wyoming Drug Utilization Review Board Public Comment Policy is available at Public Comment Policy.

  2. The first two hours of each meeting will be devoted to discussions about HCF, impending legislation, newsletter content, criteria changes and disease management initiatives. PhRMA representatives may be present during this portion of the meeting.

  3.  The last two hours of each meeting will be devoted to confidential discussions of individual patient profiles, specific patient and provider initiatives and individual provider profiles.  PhRMA representatives would not be able to be present during this portion of the meeting.

  4.   The Wyoming DUR Board meeting schedule and locations are available at the WYDUR website: www.uwyo.edu/DUR or you may call the University Of Wyoming School Of Pharmacy at 307-766-6750.

  5.  The relevant Wyoming statutes are under Article 4: Public Meetings in the Uniform Municipal Fiscal Procedures.

16-4-405            “A governing body of an agency may hold executive sessions not open to the public: (ix) To consider or receive any information classified as confidential by law;

16-4-406            “If any public meeting is willfully disrupted by a person or group of persons so as to render the orderly conduct of the meeting unfeasible, and order cannot be restored by the removal of the person or persons who are willfully interrupting the meeting, the governing body of an agency may order the removal of the person or group from the meeting room and continue in session, or may recess the meeting and reconvene at another location.”

16-4-407            (b) “The custodian may deny the right of inspection of the following records; (d) (i) Medical, psychological and sociological data on individual persons, exclusive of coroners’ autopsy reports;”

 Revised October 2006